Vyne Therapeutics Inc (NASDAQ:VYNE)

0.2232
Delayed Data
As of Nov 30
 +0.0033 / +1.44%
Today’s Change
0.22
Today|||52-Week Range
1.75
-78.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.00674.0K4.6M10.6M
 
 
 
 
Depreciation And Amortization0.004.0K8.0K22.0K
 
 
 
 
 
Operating ExpensesGross Income0.00--------
General Expenses4.6M15.0M34.2M65.2M
 
 
 
 
 
Research And Development2.9M11.3M29.0M53.0M
 
 
 
 
 
Total Operating Expenses4.6M15.0M34.2M65.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.6M-14.3M-29.6M-54.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.6M-14.1M-29.1M-51.4M
 
 
 
 
 
Net Income-4.6M-14.1M-29.1M-51.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS21.4M23.0M23.0M21.7M
 
 
 
 
 
Shares To Calculate EPS Diluted21.4M23.0M23.0M21.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.22-$0.61-$1.27-$2.37
 
 
 
 
 
EPS Diluted-$0.22-$0.61-$1.27-$2.37